| Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis JH Kim, KH Han, EY Park, ET Kim, EJ Kim, DSP Tan, JY Lee, SY Park, ... Gynecologic Oncology 187, 85-91, 2024 | | 2024 |
| A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in … L Bravo, JFF Simões, VR Cardoso, A Adisa, ML Aguilera, A Arnaud, ... The Lancet Digital Health 6 (7), e507-e519, 2024 | | 2024 |
| British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024 E Moss, A Taylor, A Andreou, C Ang, R Arora, A Attygalle, S Banerjee, ... European Journal of Obstetrics and Gynecology and Reproductive Biology, 2024 | | 2024 |
| Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic S Nasser, C Fotopoulou, M Gültekin, D Dimitrova, E Bilir, G Inci, P Morice, ... Archives of Gynecology and Obstetrics, 1-10, 2024 | | 2024 |
| Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification D Mutch, D Gaffney, X Matias-Guiu, C Fotopoulou, N Concin, JS Berek, ... International journal of gynaecology and obstetrics: the official organ of …, 2024 | | 2024 |
| Contraceptive strategies for reducing the risk of reproductive cancers AR Aliabadi, S Wilailak, O McNally, JS Berek, A Sridhar, ... International Journal of Gynecology & Obstetrics, 2024 | | 2024 |
| 2023 FIGO staging system for endometrial cancer: the evolution of the revolution D Gaffney, X Matias-Guiu, D Mutch, G Scambia, C Creutzberg, ... Gynecologic oncology 184, 245-253, 2024 | 3 | 2024 |
| Infrastructural and public health awareness gaps for the diagnosis and treatment of ovarian cancer: A literature review KB Papalois, C Fotopoulou Archives of Gynecology and Obstetrics 309 (5), 1807-1813, 2024 | | 2024 |
| Lower Limb Lymphedema Awareness among Gynecological Cancer Patients: An International Survey Supported by the European Network of Gynecological Cancer Advocacy Groups (ENGAGe … D Haidopoulos, V Pergialiotis, M Papageorgiou, MJ Halaska, K Maxova, ... Cancers 16 (8), 1544, 2024 | | 2024 |
| Abstract B104: Establishing patient derived organoids for high-grade serous ovarian cancer as representative models for pre-clinical research JJ Clark, J Krell, C Dickie, L Kondyliou, M Lorentzen, M Lythgoe, ... Cancer Research 84 (5_Supplement_2), B104-B104, 2024 | | 2024 |
| Abstract B114: Effect of spatial and temporal inter-tumoral heterogeneity on homologous recombination deficiency scores in high grade serous ovarian cancer EL Christie, M Lorentzen, M Liu, N Burdett, E Curry, CH Kwok, A Pandey, ... Cancer Research 84 (5_Supplement_2), B114-B114, 2024 | | 2024 |
| Abstract A057: Inter-tumor heterogeneity revealed by multi-site whole genome sequencing of high grade serous ovarian cancer N Burdett, C Fotopoulou, A Pandey, M Lorentzen, J Clark, J Krell, ... Cancer Research 84 (5_Supplement_2), A057-A057, 2024 | | 2024 |
| Abstract B017: Understanding the impact of transporter heterogeneity on the efficacy of PARP inhibitors CR Moncayo, G Zhang, A Barr, V Wu, C Fotopoulou, P Cunnea, Z Hall, ... Cancer Research 84 (5_Supplement_2), B017-B017, 2024 | | 2024 |
| Establishing patient derived organoids for high-grade serous ovarian cancer as representative models for pre-clinical research JJ Clark, J Krell, C Dickie, L Kondyliou, M Lorentzen, M Lythgoe, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| Effect of spatial and temporal inter-tumoral heterogeneity on homologous recombination deficiency scores in high grade serous ovarian cancer EL Christie, M Lorentzen, M Liu, N Burdett, E Curry, CH Kwok, A Pandey, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| 936 Genomic features underlying spatial heterogeneity in homologous recombination deficiency scores in ovarian high grade serous cancer M Lorentzen, E Christie, M Liu, E Curry, A Pandey, K Nixon, J Ploski, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 933 Transcriptomic heterogeneity in high grade serous ovarian cancer organoids J Clark, C Fotopoulou, L Kondyliou, C Dickie, M Lorentzen, L Gater, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| Surgery for gynecological cancers in the era of personalized medicine: a novel paradigm C Fotopoulou, AG Eriksson, G Baiocchi, O Zivanovic International Journal of Gynecologic Cancer 34 (3), 2024 | | 2024 |
| ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: Pathology and molecular biology and early, advanced and recurrent disease JA Ledermann, X Matias-Guiu, F Amant, N Concin, B Davidson, ... Annals of Oncology 35 (3), 248-266, 2024 | 24 | 2024 |
| O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery Y Dabi, A Rockall, L Razakamanantsoa, A Guerra, LS Fournier, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 294 …, 2024 | 1 | 2024 |
